Mayo Clinic Q and A: Diabetes and risk of peripheral neuropathy
DEAR MAYO CLINIC: I was diagnosed with diabetes a few months ago, and I am concerned about peripheral neuropathy in my feet. Is there anything I can do to prevent this? ANSWER: Peripheral neuropathy?is a common problem that can happen as a result of diabetes. But it isn?t inevitable. To help prevent peripheral neuropathy, closely [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 20, 2017 Category: Databases & Libraries Source Type: news

Blocking neuron signaling pathway could lead to new treatments for peripheral neuropathy
(University of California - San Diego) Researchers at University of California San Diego School of Medicine, with colleagues at the National Institute of Diabetes and Digestive and Kidney Diseases, the University of Manitoba and St. Boniface Hospital Albrechtsen Research Centre in Canada, have identified a molecular signaling pathway that, when blocked, promotes sensory neuron growth and prevents or reverses peripheral neuropathy in cell and rodent models of type 1 and 2 diabetes, chemotherapy-induced neuropathy and HIV. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2017 Category: Global & Universal Source Type: news

Frostbite
With the cold months here people need to be made aware of injuries that may occur during these months. Exposure to a temperature below freezing usually leads to severe soft tissue damage (Figure 1). How does the body protect itself from cold? Thermoregulation The body has the ability to maintain a core body temperature by the process of thermoregulation. During extreme cold, the body receives a signal from sensory receptors. For example, there receptors are present in the hands or the feet (Figure 2). These sensory receptors will respond to the cold and send a signal up to the brain. The posterior hypothalamus is respo...
Source: Healthy Living - The Huffington Post - December 27, 2016 Category: Consumer Health News Source Type: news

In the Workplace 2017: How Arkansas Employers Can Deal with Medical Marijuana
Editor's Note: This is the first of five articles this week by the labor and employment team at the law firm of Wright Lindsey Jennings of Little Rock examining key trends for employers and the workplace in 2017. Here's a quick look at important employment issues that could arise next year. Now that Arkansas is the latest state to have a medical marijuana law on the books, Arkansas employers must be prepared to address this issue. Although the amendment to the Arkansas Constitution is effective immediately, it should take some time for most Arkansas residents to take advantage of the approved use of medical ...
Source: Arkansas Business - Health Care - December 26, 2016 Category: American Health Source Type: news

Needling the Pain of Peripheral Neuropathy Needling the Pain of Peripheral Neuropathy
Pilot study suggests acupuncture gets somewhere other therapies have not in patients with breast cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 12, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Chemical compound holds promise as cancer treatment with fewer side effects than traditional chemotherapy
A synthetic version of a rare toxin produced by a sea creature appears to hold promise for treating many different types of cancer while minimizing the harmful side effects of widely used chemotherapy drugs.A study published today in the journal Science  Translational Medicine describes research on a substance called diazonamide, which prevents cell division, and was isolated from a marine animal calledDiazona angulata.Led by Patrick Harran, UCLA ’s Donald J. and Jane M. Cram Professor of Organic Chemistry, researchers produced a synthetic form of diazonamide that, in rodents, appears to be effective in fighting breast ...
Source: UCLA Newsroom: Health Sciences - November 16, 2016 Category: Universities & Medical Training Source Type: news

Are falls prevention programs effective at reducing the risk factors for falls in people with type-2 diabetes mellitus and peripheral neuropathy: a systematic review with narrative synthesis - Gu Y, Dennis SM.
BACKGROUND: Diabetic peripheral neuropathy (DPN) is a common complication of type-2 diabetes mellitus (T2DM) that predisposes the elderly to a higher falls risk. Falls prevention programs with a component of weight-bearing exercises are effective in decrea... (Source: SafetyLit)
Source: SafetyLit - November 11, 2016 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Medical Marijuana: A Fact of Life for Arkansas Employers (Stuart Jackson Commentary)
The election is over, and Arkansas is now the latest of many states to have a medical marijuana law on the books.  Although the new amendment to the Arkansas Constitution is effective immediately, it should take some time for the approved use of medical marijuana to begin. At the very least, someone has to design and print the required "Registry Identification Cards" for users — unless one of your employees shows up with a registry identification card from another state and claims to be a "visiting qualifying patient."   So, what does the new law do? It allows (among other things) "qualifying patients" who ...
Source: Arkansas Business - Health Care - November 10, 2016 Category: American Health Source Type: news

Aptinyx Receives FDA Fast Track Designation for Development of NYX-2925 as Treatment for Neuropathic Pain Associated with Diabetic Peripheral Neuropathy
EVANSTON, Ill., Sept. 13, 2016 -- (Healthcare Sales & Marketing Network) -- Aptinyx Inc., a biopharmaceutical company developing novel modulators of the N-methyl-D-aspartate (NMDA) receptor for the treatment of challenging neurologic disorders, today anno... Biopharmaceuticals, Neurology, FDA Aptinyx, NMDA, Neuropathic Pain, Diabetic Peripheral Neuropathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2016 Category: Pharmaceuticals Source Type: news

Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk - Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ.
Chemotherapy-induced peripheral neuropathy (CIPN) is a common toxicity associated with chemotherapy, but researchers rarely study its risk factors, fall risk, and prevalence in long-term breast cancer survivors. We aimed to determine CIPN prevalence, risk ... (Source: SafetyLit)
Source: SafetyLit - September 12, 2016 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Complex and simple clinical reaction times are associated with gait, balance, and major fall injury in older subjects with diabetic peripheral neuropathy - Richardson JK, Eckner JT, Allet L, Kim H, Ashton-Miller JA.
OBJECTIVE: The aim of this work was to identify relationships between complex and simple clinical measures of reaction time (RTclin) and indicators of balance in older subjects with and without diabetic peripheral neuropathy (DPN). DESIGN: Prospect... (Source: SafetyLit)
Source: SafetyLit - August 25, 2016 Category: Global & Universal Tags: Age: Elder Adults Source Type: news

NIH grant will fund new JAX Resource for Research of Peripheral Neuropathy
(Jackson Laboratory) The National Institute of Neurological Disorders and Stroke has made a grant to The Jackson Laboratory to develop mouse models for inherited peripheral neuropathies and neurodegenerative diseases including Charcot-Marie-Tooth disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 17, 2016 Category: Global & Universal Source Type: news

MDI Biological Laboratory receives funds for research on nerve damage
(Mount Desert Island Biological Laboratory) The MDI Biological Laboratory has announced that it has received a grant of $456,500 over two years from the National Institutes of Health (NIH) for the study of peripheral neuropathy. The grant from the National Institute of Neurological Disorders and Stroke will support research conducted by assistant professor Sandra Rieger, Ph.D., on chemotherapy-induced peripheral neuropathy, a disabling condition causing pain, numbness, tingling and temperature sensitivity in the distal extremities. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 17, 2016 Category: Cancer & Oncology Source Type: news

Voodoo Medicine: Time To Stop
The world's most celebrated athlete standing on the podium in Rio in honor of receiving yet another gold medal has something important in common with your lazy uncle throwing back a cold one in his Barcalounger. Yes, swimming powerhouse Michael Phelps, purple-spotted from cupping therapy, and your slovenly relative with a beer gut both share a bond -- a weakness in succumbing to the allure of voodoo medicine. Modern-day snake oil salesmen hawking quick cures and TV doctors peddling the latest diet miracle with blatantly ridiculous claims are everywhere on the tube, social media, the supermarket and old-fashioned billboards...
Source: Science - The Huffington Post - August 12, 2016 Category: Science Source Type: news

A potential target for peripheral neuropathy treatment discovered
Whole exome sequencing has revealed a novel mechanism and potential target for treating peripheral neuropathy, a condition that afflicts millions of people in the United States alone. (Source: Yale Science and Health News)
Source: Yale Science and Health News - August 2, 2016 Category: Universities & Medical Training Tags: Yale News Source Type: news